Three new diabetes drugs come under the scanner of US drug regulator

Three new diabetes drugs come under the scanner of US drug regulator 

Three new type-2 diabetes medicines, two of which were recently launched in India, have come under the scanner of the US drug regulator for potential risk of causing acidosis that could require hospitalization.

The US Food and Drug Administration (FDA) has warned medical professionals and patients that type-2 diabetes medicines – canagliflozin, dapagliflozin, and empagliflozin – may cause high levels of blood acids which can lead to serious adverse effects.

The three drugs, a ..